AAAAAA

   
Results: 1-9 |
Results: 9
Expression of human endogenous retrovirus K envelope transcripts in human breast cancer
Authors: Wang-Johanning, F Frost, AR Johanning, GL Khazaeli, MB LoBuglio, AF Shaw, DR Strong, TV
Citation: F. Wang-johanning et al., Expression of human endogenous retrovirus K envelope transcripts in human breast cancer, CLIN CANC R, 7(6), 2001, pp. 1553-1560
Adenoviral-mediated suicide gene therapy for ovarian cancer
Authors: Alvarez, RD Gomez-Navarro, J Wang, MH Barnes, MN Strong, TV Arani, RB Arafat, W Hughes, JV Siegal, GP Curiel, DT
Citation: Rd. Alvarez et al., Adenoviral-mediated suicide gene therapy for ovarian cancer, MOL THER, 2(5), 2000, pp. 524-530
Development of a polynucleotide vaccine from melanoma antigen recognized by T cells-1 and recombinant protein from melanoma antigen recognized by T cells-1 for melanoma vaccine clinical trials
Authors: Lee, SW Li, H Strong, TV Moore, SE Conry, RM
Citation: Sw. Lee et al., Development of a polynucleotide vaccine from melanoma antigen recognized by T cells-1 and recombinant protein from melanoma antigen recognized by T cells-1 for melanoma vaccine clinical trials, J IMMUNOTH, 23(3), 2000, pp. 379-386
Gene therapy for carcinoma of the breast - Genetic immunotherapy
Authors: Strong, TV
Citation: Tv. Strong, Gene therapy for carcinoma of the breast - Genetic immunotherapy, BREAST CA R, 2(1), 2000, pp. 15-21
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial
Authors: Alvarez, RD Barnes, MN Gomez-Navarro, J Wang, MH Strong, TV Arafat, W Arani, RB Johnson, MR Roberts, BL Siegal, GP Curiel, DT
Citation: Rd. Alvarez et al., A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial, CLIN CANC R, 6(8), 2000, pp. 3081-3087
Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid
Authors: Blackwell, JL Li, H Gomez-Navarro, J Dmitriev, I Krasnykh, V Richter, CA Shaw, DR Alvarez, RD Curiel, DT Strong, TV
Citation: Jl. Blackwell et al., Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid, HUM GENE TH, 11(12), 2000, pp. 1657-1669
SEREX analysis for tumor antigen identification in a mouse model of adenocarcinoma
Authors: Hampton, TA Conry, RM Khazaeli, MB Shaw, DR Curiel, DT LoBuglio, AF Strong, TV
Citation: Ta. Hampton et al., SEREX analysis for tumor antigen identification in a mouse model of adenocarcinoma, CANC GENE T, 7(3), 2000, pp. 446-455
Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
Authors: Kasono, K Blackwell, JL Douglas, JT Dmitriev, I Strong, TV Reynolds, P Kropf, DA Carroll, WR Peters, GE Bucy, RP Curiel, DT Krasnykh, V
Citation: K. Kasono et al., Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector, CLIN CANC R, 5(9), 1999, pp. 2571-2579
Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma
Authors: Blackwell, JL Miller, CR Douglas, JT Li, H Reynolds, PN Carroll, WR Peters, GE Strong, TV Curiel, DT
Citation: Jl. Blackwell et al., Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma, ARCH OTOLAR, 125(8), 1999, pp. 856-863
Risultati: 1-9 |